Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications.
Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications.
Cardiovasc Hematol Disord Drug Targets. 2015;15(2):115-9
Authors: Huseynov A, Baumann S, El-Battrawy I, Akin I
Abstract
The use of novel oral anticoagulation (NOACs) has emerged as an alternative for oral anticoagulation with vitamin-K antagonists in different clinical settings. However, despite the several advantages of these new drugs, there are also several limitations and cautious is recommended in different clinical settings in patients with a high comorbidity index. This review article will describe the current evidence of treatment monitoring, possible drug interaction, and will give an overview about treatment options in case of complications.
PMID: 26666329 [PubMed - in process]
Source: Cardiovascular and Hematological Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Cardiovasc Hematol Disord Drug Targets Source Type: research
More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Heart | Hematology | Laboratory Medicine | Vitamins